Drugs / Ga-68-CXCR4
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06461182 | Apr 2024 → Apr 2026 overdue | indolent B-cell non-Hodgkin lymphoma | Koo Foundation Sun Yat-Sen Cancer Center | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ga-68-CXCR4 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06461182 ↗ |